[144] Alignment Healthcare, Inc. SEC Filing

Issuer filed a Form 144 disclosing proposed sales and recent dispositions of Common Stock.

Rhea-AI Filing Summary

Issuer filed a Form 144 disclosing proposed sales and recent dispositions of Common Stock. The filing lists 596,000 shares originally issued pre-IPO in exchange for partnership units. It also itemizes multiple 10b5-1 plan and individual sales in March–April 2026, including 250,000 shares sold on 04/07/2026 for $5,252,900.

Insights

Securities Attorney

Routine resale disclosure under Rule 144 documenting planned and recent sales.

The filing lists a 596,000-share block characterized as shares issued pre-IPO in exchange for partnership units and shows multiple dispositions executed under a 10b5-1 Sales Plan and by an individual. The document is a transfer/resale notice, not an operational update.

Timing and cash recipients are the selling holders and not the issuer; cash‑flow treatment is stated by the transactions themselves. Subsequent filings may show additional resale activity or completion notices.

Key Figures

Shares issued pre-IPO: 596,000 shares Sale on 04/07/2026: 250,000 shares Sale on 04/10/2026: 215,701 shares +3 more

6 metrics

Shares issued pre-IPO 596,000 shares Issued in exchange for Partnership Units (05/09/2014)

Sale on 04/07/2026 250,000 shares 10b5-1 Sales Plan disposition for <money>$5,252,900</money>

Sale on 04/10/2026 215,701 shares 10b5-1 Sales Plan disposition for <money>$4,450,278.32</money>

Sale on 04/13/2026 82,299 shares 10b5-1 Sales Plan disposition for <money>$1,711,654.60</money>

Sale on 03/18/2026 by John E. Kao 73,046 shares Individual disposition for <money>$1,303,140.64</money>

Sale on 03/12/2026 by John E. Kao 48,899 shares Individual disposition for <money>$853,125.50</money>

Key Terms

10b5-1 Sales Plan, Form 144, Issued Pre-IPO

3 terms

10b5-1 Sales Plan regulatory

"10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021"

A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issued Pre-IPO market

"Shares Issued Pre-IPO in exchange for Partnership Units"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ALHC's Form 144 report?

It reports proposed and recent sales of Common Stock, including a 596,000-share lot issued pre-IPO. The filing itemizes executed sales under a 10b5-1 plan and individual dispositions dated March–April 2026.

Who executed the sales listed in the Form 144?

The sales are attributed to the JEK Trust u/a dated 02/08/2021 under a 10b5-1 plan and to John E. Kao as an individual, according to the itemized transaction rows in the filing.

How many shares were sold on 04/07/2026?

The filing shows 250,000 shares sold on 04/07/2026 for $5,252,900, listed as an executed disposition in the sales table associated with the 10b5-1 plan.

Are the 596,000 shares registered or reserved?

The filing describes 596,000 shares as "Shares Issued Pre-IPO in exchange for Partnership Units." It is a disclosure of ownership and planned resale activity rather than a registration statement.

Does the Form 144 show proceeds going to the company?

Proceeds shown in the itemized rows correspond to sales by the trust and individual sellers; the filing does not indicate proceeds being paid to the issuer in those transaction lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001222028
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALIGNMENT HEALTHCARE INC
SEC File Number	001-40295
Address of Issuer	1100 W. Town and Country Road Orange CALIFORNIA 92868
Phone	8443102247
Name of Person for Whose Account the Securities are To Be Sold	JEK TRUST U/A DTD 02/08/2021
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	596000	10686280.00	206733823	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2014	Shares Issued Pre-IPO in exchange for Partnership Units	Issuer			596000	05/09/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	04/13/2026	82299	1711654.60
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	04/10/2026	215701	4450278.32
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	04/07/2026	250000	5252900.00
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	03/23/2026	118000	2062435.60
JOHN E KAO 1100 W. Town and Country Road Orange CA 92868	Common	03/18/2026	73046	1303140.64
JOHN E KAO 1100 W. Town and Country Road Orange CA 92868	Common	03/12/2026	48899	853125.50
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Orange CA 92868	Common	03/10/2026	180000	3273558.00

144: Remarks and Signature

Remarks	The securities to be sold were Shares Issued Pre-IPO in exchange for Partnership Units during the period of 05/09/2014 through 09/07/2025.
Date of Notice	05/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Kao
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)